Search General Info
Search Education
Search Partnering Companies

Andrew Saxon, MD

Santa Monica, California, United States
Andrew Saxon, MD is the CEO and President of Sixal Inc. and devotes more than 80% of his time to the company. He was Professor and Chief of Clinical Immunology/Allergy at the David Geffen School of Medicine at UCLA for more than 30 years. His expertise is in the cellular and molecular biology of human allergic disease and translating this from the bench to the bedside. For over a decade, he was Chairman of the Allergy/Asthma Section of the Immune Tolerance Network and a member of its National Scientific Council. He is past chair of the Medical Advisory Boards for both the Food Allergy Initiative and the Food Allergy & Anaphylaxis Network that have now joined to form the Food Allergy Research
Speaking In
[On Demand]

Sixal is a pre-clinical biotech company developing a novel monoclonal antibody for treatment of…